The global biosimilars market size is calculated at USD 40.36 billion in 2025 and is forecasted to hit around USD 175.99 billion by 2034, representing a CAGR of 17.78% from 2025 to 2034. The Europe market size is evaluated at USD 15.37 billion in 2025 and is expanding at a CAGR of 17.34% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biosimilars Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biosimilars Market, by Product
8.1.1. Monoclonal Antibodies
8.1.1.1. Market Revenue and Forecast
8.1.2. Insulin
8.1.2.1. Market Revenue and Forecast
8.1.3. Granulocyte Colony-Stimulating Factor
8.1.3.1. Market Revenue and Forecast
8.1.4. Erythropoietin
8.1.4.1. Market Revenue and Forecast
8.1.5. Recombinant Human Growth Hormone
8.1.5.1. Market Revenue and Forecast
8.1.6. Etanercept
8.1.6.1. Market Revenue and Forecast
8.1.7. Follitropin
8.1.7.1. Market Revenue and Forecast
8.1.8. Teriparatide
8.1.8.1. Market Revenue and Forecast
8.1.9. Interferons
8.1.9.1. Market Revenue and Forecast
8.1.10. Anticoagulants
8.1.10.1. Market Revenue and Forecast
8.1.11. Other
8.1.11.1. Market Revenue and Forecast
9.1. Biosimilars Market, by Application
9.1.1. Oncology
9.1.1.1. Market Revenue and Forecast
9.1.2. Growth Hormonal Deficiency
9.1.2.1. Market Revenue and Forecast
9.1.3. Blood Disorders
9.1.3.1. Market Revenue and Forecast
9.1.4. Chronic & Autoimmune Disorders
9.1.4.1. Market Revenue and Forecast
9.1.5. Infectious Disease
9.1.5.1. Market Revenue and Forecast
9.1.6. Others
9.1.6.1. Market Revenue and Forecast
10.1. Biosimilars Market, by Manufacturer
10.1.1. Contract Research and Manufacturing Services
10.1.1.1. Market Revenue and Forecast
10.1.2. In-house
10.1.2.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Application
11.1.3. Market Revenue and Forecast, by Manufacturer
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product
11.1.4.2. Market Revenue and Forecast, by Application
11.1.4.3. Market Revenue and Forecast, by Manufacturer
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by Application
11.1.5.3. Market Revenue and Forecast, by Manufacturer
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by Application
11.2.3. Market Revenue and Forecast, by Manufacturer
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product
11.2.4.2. Market Revenue and Forecast, by Application
11.2.4.3. Market Revenue and Forecast, by Manufacturer
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by Application
11.2.5.3. Market Revenue and Forecast, by Manufacturer
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by Application
11.2.6.3. Market Revenue and Forecast, by Manufacturer
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by Application
11.2.7.3. Market Revenue and Forecast, by Manufacturer
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by Application
11.3.3. Market Revenue and Forecast, by Manufacturer
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product
11.3.4.2. Market Revenue and Forecast, by Application
11.3.4.3. Market Revenue and Forecast, by Manufacturer
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by Application
11.3.5.3. Market Revenue and Forecast, by Manufacturer
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by Application
11.3.6.3. Market Revenue and Forecast, by Manufacturer
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by Application
11.3.7.3. Market Revenue and Forecast, by Manufacturer
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by Application
11.4.3. Market Revenue and Forecast, by Manufacturer
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by Application
11.4.4.3. Market Revenue and Forecast, by Manufacturer
11.4.4. North Africa
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by Application
11.4.4.3. Market Revenue and Forecast, by Manufacturer
11.4.5. South Africa
11.4.5.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by Application
11.4.5.3. Market Revenue and Forecast, by Manufacturer
11.4.6. Rest of MEA
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by Application
11.4.6.3. Market Revenue and Forecast, by Manufacturer
11.7. Latin America
11.7.1. Market Revenue and Forecast, by Product
11.7.2. Market Revenue and Forecast, by Application
11.7.3. Market Revenue and Forecast, by Manufacturer
11.8. Brazil
11.4.8.1. Market Revenue and Forecast, by Product
11.4.8.2. Market Revenue and Forecast, by Application
11.4.8.3. Market Revenue and Forecast, by Manufacturer
11.9. Rest of LATAM
11.4.9.1. Market Revenue and Forecast, by Product
11.4.9.2. Market Revenue and Forecast, by Application
11.4.9.3. Market Revenue and Forecast, by Manufacturer
12.1. Novartis
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Synthon Pharmaceuticals, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. TevaPharmaceutical Industries Ltd.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. LG Life Sciences
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Celltrion
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Biocon
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Hospira
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Merck Serono
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Biogen idec, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Genentech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample